NASDAQ:STAA STAAR Surgical (STAA) Stock Forecast, Price & News $59.79 +0.47 (+0.79%) (As of 05/26/2023 08:47 PM ET) Add Compare Share Share Today's Range$58.54▼$60.7950-Day Range$58.96▼$72.8252-Week Range$46.35▼$112.27Volume440,700 shsAverage Volume671,357 shsMarket Capitalization$2.89 billionP/E Ratio93.42Dividend YieldN/APrice Target$81.18 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability STAAR Surgical MarketRank™ ForecastAnalyst RatingModerate Buy2.73 Rating ScoreUpside/Downside35.8% Upside$81.18 Price TargetShort InterestBearish12.77% of Shares Sold ShortDividend StrengthN/ASustainability-0.73Upright™ Environmental ScoreNews Sentiment0.83Based on 12 Articles This WeekInsider TradingSelling Shares$51,001 Sold Last QuarterProj. Earnings Growth91.23%From $0.57 to $1.09 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.72 out of 5 starsMedical Sector91st out of 1,012 stocksOphthalmic Goods Industry1st out of 7 stocks 3.4 Analyst's Opinion Consensus RatingSTAAR Surgical has received a consensus rating of Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $81.18, STAAR Surgical has a forecasted upside of 35.8% from its current price of $59.79.Amount of Analyst CoverageSTAAR Surgical has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted12.77% of the outstanding shares of STAAR Surgical have been sold short.Short Interest Ratio / Days to CoverSTAAR Surgical has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous monthShort interest in STAAR Surgical has recently decreased by 3.59%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldSTAAR Surgical does not currently pay a dividend.Dividend GrowthSTAAR Surgical does not have a long track record of dividend growth. Previous Next 4.1 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSTAAR Surgical has received a 58.64% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Intraocular lenses" product. See details.Environmental SustainabilityThe Environmental Impact score for STAAR Surgical is -0.73. Previous Next 3.2 News and Social Media Coverage News SentimentSTAAR Surgical has a news sentiment score of 0.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for STAAR Surgical this week, compared to 4 articles on an average week.Search Interest4 people have searched for STAA on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.MarketBeat Follows3 people have added STAAR Surgical to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STAAR Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $51,001.00 in company stock.Percentage Held by InsidersOnly 1.10% of the stock of STAAR Surgical is held by insiders.Percentage Held by Institutions97.55% of the stock of STAAR Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for STAAR Surgical are expected to grow by 91.23% in the coming year, from $0.57 to $1.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STAAR Surgical is 93.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 134.76.Price to Earnings Ratio vs. SectorThe P/E ratio of STAAR Surgical is 93.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 133.46.Price to Book Value per Share RatioSTAAR Surgical has a P/B Ratio of 8.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About STAAR Surgical (NASDAQ:STAA) StockSTAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.Read More Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Stock News HeadlinesMay 27, 2023 | msn.comI See Opportunity In STAAR SurgicalMay 26, 2023 | finance.yahoo.comSTAAR Surgical Company (NASDAQ:STAA) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?May 29, 2023 | Stocks To Trade (Ad)3 Free Stock Picks per DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 25, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Shares Down 6.1% May 24, 2023 | msn.comNeedham Reiterates Staar Surgical (STAA) Buy RecommendationMay 24, 2023 | markets.businessinsider.comWhat 4 Analyst Ratings Have To Say About Staar SurgicalMay 24, 2023 | msn.comSTAAR Surgical: Revising To Hold Until Starting Valuations Improve (Rating Downgrade)May 22, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Research Coverage Started at StockNews.comMay 29, 2023 | Stocks To Trade (Ad)3 Free Stock Picks per DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 22, 2023 | americanbankingnews.comBrokerages Set STAAR Surgical (NASDAQ:STAA) PT at $82.60May 16, 2023 | marketwatch.com2023-2030 Ophthalmic Surgical Devices Market Classification-Know Your Target AudienceMay 11, 2023 | marketwatch.comPhakic Intraocular Lens (PIOL) Market Medical Industry Emerging Trend and Global Demand 2023 to 2030 STAAR Surgical, Ophtec B.V., Johnson JohnsonMay 9, 2023 | finance.yahoo.comSTAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To ContinueMay 8, 2023 | markets.businessinsider.comBTIG Sticks to Their Buy Rating for Treace Medical Concepts (TMCI)May 8, 2023 | markets.businessinsider.comBTIG Remains a Buy on Vicarious Surgical (RBOT)May 8, 2023 | marketwatch.comOphthalmic Surgical Instruments Market Growth Rate and Size in The Coming Year from 2023-2030May 7, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Price Target Raised to $84.00May 7, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) Upgraded at StockNews.comMay 5, 2023 | msn.comUnusual Call Option Trade in Staar Surgical (STAA) Worth $65.00KMay 5, 2023 | marketwatch.comSpheric Lenses Market 2023 Future Size And Growth of a MarketMay 5, 2023 | americanbankingnews.comSTAAR Surgical (NASDAQ:STAA) & Innovative Eyewear (NASDAQ:LUCY) Financial ComparisonMay 4, 2023 | msn.comNeedham Maintains Staar Surgical (STAA) Buy RecommendationMay 4, 2023 | msn.comStephens & Co. Reiterates Staar Surgical (STAA) Overweight RecommendationMay 4, 2023 | benzinga.comStaar Surgical shares are trading lower after the company reported Q1 financial results.May 4, 2023 | markets.businessinsider.comAnalyst Ratings for Staar SurgicalMay 4, 2023 | finance.yahoo.comEVO ICL Sponsors Jonas Brothers’ The TourMay 3, 2023 | markets.businessinsider.comBTIG Sticks to Their Buy Rating for Glaukos (GKOS)See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive STAA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STAAR Surgical and its competitors with MarketBeat's FREE daily newsletter. Email Address STAA Company Calendar Last Earnings11/03/2021Today5/29/2023Next Earnings (Estimated)8/09/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Ophthalmic goods Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:STAA CUSIP85231230 CIK718937 Webwww.staar.com Phone(626) 303-7902Fax626-303-2962Employees692Year Founded1982Price Target and Rating Average Stock Price Forecast$81.18 High Stock Price Forecast$125.00 Low Stock Price Forecast$60.00 Forecasted Upside/Downside+35.8%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$0.64 Trailing P/E Ratio93.42 Forward P/E Ratio104.89 P/E GrowthN/ANet Income$38.76 million Net Margins10.81% Pretax Margin13.15% Return on Equity9.85% Return on Assets7.93% Debt Debt-to-Equity RatioN/A Current Ratio6.65 Quick Ratio6.06 Sales & Book Value Annual Sales$284.39 million Price / Sales10.16 Cash Flow$0.89 per share Price / Cash Flow67.04 Book Value$7.01 per share Price / Book8.53Miscellaneous Outstanding Shares48,330,000Free Float47,801,000Market Cap$2.89 billion OptionableOptionable Beta1.23 Social Links Key ExecutivesThomas G. FrinziChairman, President & Chief Executive OfficerWarren FoustChief Operating OfficerPatrick F. WilliamsChief Financial Officer & Vice PresidentKeith HollidayChief Technology OfficerScott D. BarnesChief Medical OfficerKey CompetitorsNational VisionNASDAQ:EYEWarby ParkerNYSE:WRBYRxSightNASDAQ:RXSTBausch + LombNYSE:BLCOGlaukosNYSE:GKOSView All CompetitorsInsiders & InstitutionsProShare Advisors LLCSold 1,358 shares on 5/26/2023Ownership: 0.018%Royce & Associates LPSold 14,000 shares on 5/23/2023Ownership: 0.089%Ameriprise Financial Inc.Sold 543 shares on 5/22/2023Ownership: 0.132%Putnam Investments LLCSold 1,101 shares on 5/22/2023Ownership: 0.054%New York State Common Retirement FundSold 7,543 shares on 5/18/2023Ownership: 0.104%View All Insider TransactionsView All Institutional Transactions STAA Stock - Frequently Asked Questions Should I buy or sell STAAR Surgical stock right now? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last twelve months. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" STAA shares. View STAA analyst ratings or view top-rated stocks. What is STAAR Surgical's stock price forecast for 2023? 11 brokers have issued 1-year target prices for STAAR Surgical's stock. Their STAA share price forecasts range from $60.00 to $125.00. On average, they expect the company's share price to reach $81.18 in the next twelve months. This suggests a possible upside of 35.8% from the stock's current price. View analysts price targets for STAA or view top-rated stocks among Wall Street analysts. How have STAA shares performed in 2023? STAAR Surgical's stock was trading at $48.54 on January 1st, 2023. Since then, STAA stock has increased by 23.2% and is now trading at $59.79. View the best growth stocks for 2023 here. When is STAAR Surgical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023. View our STAA earnings forecast. How were STAAR Surgical's earnings last quarter? STAAR Surgical (NASDAQ:STAA) announced its quarterly earnings data on Wednesday, November, 3rd. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.11 by $0.01. The medical instruments supplier earned $58.35 million during the quarter, compared to the consensus estimate of $57.70 million. STAAR Surgical had a net margin of 10.81% and a trailing twelve-month return on equity of 9.85%. During the same quarter in the prior year, the company earned $0.14 EPS. What ETFs hold STAAR Surgical's stock? ETFs with the largest weight of STAAR Surgical (NASDAQ:STAA) stock in their portfolio include Janus Henderson Small Cap Growth Alpha ETF (JSML), SPDR S&P Health Care Equipment ETF (XHE), ROBO Global Healthcare Technology and Innovation ETF (HTEC), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Pacer US Export Leaders ETF (PEXL), Janus Henderson US Sustainable Equity ETF (SSPX), RiverFront Dynamic US Flex-Cap ETF (RFFC) and Principal U.S. Small-Cap Multi-Factor ETF (PSC). What guidance has STAAR Surgical issued on next quarter's earnings? STAAR Surgical issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $348.00 million-$348.00 million, compared to the consensus revenue estimate of $341.43 million. What is Caren Mason's approval rating as STAAR Surgical's CEO? 6 employees have rated STAAR Surgical Chief Executive Officer Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among the company's employees. What other stocks do shareholders of STAAR Surgical own? Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU). What is STAAR Surgical's stock symbol? STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA." Who are STAAR Surgical's major shareholders? STAAR Surgical's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (12.11%), Baillie Gifford & Co. (10.60%), Anatole Investment Management Ltd (4.23%), State Street Corp (3.48%), Palo Alto Investors LP (2.79%) and Geode Capital Management LLC (1.95%). Insiders that own company stock include Broadwood Partners, LP, Caren L Mason, Graydon C Hansen, Hans-Martin Blickensdoerfer, James E Francese, Jon K Hayashida, Keith Holliday, Patrick F Williams and Samuel J Gesten. View institutional ownership trends. How do I buy shares of STAAR Surgical? Shares of STAA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is STAAR Surgical's stock price today? One share of STAA stock can currently be purchased for approximately $59.79. How much money does STAAR Surgical make? STAAR Surgical (NASDAQ:STAA) has a market capitalization of $2.89 billion and generates $284.39 million in revenue each year. The medical instruments supplier earns $38.76 million in net income (profit) each year or $0.64 on an earnings per share basis. How many employees does STAAR Surgical have? The company employs 692 workers across the globe. Does STAAR Surgical have any subsidiaries? The following companies are subsidiares of STAAR Surgical: Canon Staar, Frigitronics Inc., STAAR Japan Inc., STAAR Optical Equipment, STAAR Surgical AG, STAAR Surgical PTE. LTD, and Technology (Shanghai) Co. LTD.Read More How can I contact STAAR Surgical? STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The official website for the company is www.staar.com. The medical instruments supplier can be reached via phone at (626) 303-7902, via email at bmoore@staar.com, or via fax at 626-303-2962. This page (NASDAQ:STAA) was last updated on 5/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.